Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD3
|
ENSG00000166949.11 | SMAD family member 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_67224686_67224837 | SMAD3 | 131340 | 0.050101 | 0.95 | 8.6e-05 | Click! |
chr15_67458204_67458355 | SMAD3 | 78 | 0.977739 | 0.95 | 1.1e-04 | Click! |
chr15_67458623_67458774 | SMAD3 | 171 | 0.960628 | 0.94 | 1.4e-04 | Click! |
chr15_67492392_67492556 | SMAD3 | 15361 | 0.202510 | 0.94 | 1.9e-04 | Click! |
chr15_67417692_67417846 | SMAD3 | 285 | 0.930307 | 0.93 | 2.3e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_55998538_55999092 | 0.97 |
SSC5D |
scavenger receptor cysteine rich domain containing (5 domains) |
956 |
0.27 |
chr11_65257627_65258285 | 0.89 |
SCYL1 |
SCY1-like 1 (S. cerevisiae) |
34592 |
0.08 |
chr11_72020089_72020240 | 0.84 |
CLPB |
ClpB caseinolytic peptidase B homolog (E. coli) |
536 |
0.69 |
chr1_234755566_234755985 | 0.78 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
10504 |
0.19 |
chr7_134574979_134575413 | 0.69 |
CALD1 |
caldesmon 1 |
955 |
0.69 |
chr1_116039442_116039593 | 0.68 |
ENSG00000265534 |
. |
11245 |
0.27 |
chr17_76370784_76371498 | 0.67 |
PGS1 |
phosphatidylglycerophosphate synthase 1 |
3580 |
0.16 |
chr7_80352686_80352837 | 0.67 |
CD36 |
CD36 molecule (thrombospondin receptor) |
50069 |
0.19 |
chr9_130284478_130284823 | 0.66 |
FAM129B |
family with sequence similarity 129, member B |
46717 |
0.09 |
chr16_57798443_57798674 | 0.65 |
KIFC3 |
kinesin family member C3 |
257 |
0.89 |
chr8_23213962_23214375 | 0.65 |
LOXL2 |
lysyl oxidase-like 2 |
14471 |
0.16 |
chr5_52718812_52718963 | 0.64 |
FST |
follistatin |
57352 |
0.16 |
chr18_55873061_55873212 | 0.62 |
RP11-718I15.1 |
|
10208 |
0.22 |
chr1_68190930_68191081 | 0.60 |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
40121 |
0.15 |
chr10_111655218_111655499 | 0.60 |
XPNPEP1 |
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble |
12219 |
0.21 |
chr17_75118947_75119098 | 0.60 |
SEC14L1 |
SEC14-like 1 (S. cerevisiae) |
4933 |
0.22 |
chr5_102785874_102786025 | 0.59 |
NUDT12 |
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
112541 |
0.07 |
chr7_157102085_157102478 | 0.59 |
ENSG00000266453 |
. |
3794 |
0.28 |
chr10_79152930_79153197 | 0.59 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
10679 |
0.24 |
chr1_120174414_120175022 | 0.59 |
ZNF697 |
zinc finger protein 697 |
15678 |
0.18 |
chr1_56046295_56046737 | 0.58 |
ENSG00000272051 |
. |
95871 |
0.09 |
chr3_55195992_55196143 | 0.57 |
LRTM1 |
leucine-rich repeats and transmembrane domains 1 |
194952 |
0.03 |
chr6_119469482_119469711 | 0.57 |
FAM184A |
family with sequence similarity 184, member A |
756 |
0.75 |
chr4_5755349_5755500 | 0.56 |
EVC |
Ellis van Creveld syndrome |
42482 |
0.16 |
chr1_201717737_201718015 | 0.55 |
NAV1 |
neuron navigator 1 |
8880 |
0.13 |
chr17_27045400_27045747 | 0.54 |
RAB34 |
RAB34, member RAS oncogene family |
126 |
0.8 |
chr9_695641_695792 | 0.54 |
RP11-130C19.3 |
|
10161 |
0.22 |
chr13_91068237_91068388 | 0.54 |
ENSG00000207858 |
. |
184876 |
0.03 |
chr14_76289096_76289247 | 0.54 |
RP11-270M14.4 |
|
14383 |
0.24 |
chr6_18043310_18043548 | 0.54 |
KIF13A |
kinesin family member 13A |
55575 |
0.13 |
chr1_17275864_17276015 | 0.54 |
CROCC |
ciliary rootlet coiled-coil, rootletin |
26689 |
0.11 |
chr10_51060106_51060257 | 0.53 |
PARG |
poly (ADP-ribose) glycohydrolase |
70534 |
0.1 |
chr7_18809339_18809490 | 0.53 |
ENSG00000222164 |
. |
38488 |
0.21 |
chr22_45949176_45949470 | 0.52 |
FBLN1 |
fibulin 1 |
34660 |
0.15 |
chr14_55914091_55914242 | 0.52 |
TBPL2 |
TATA box binding protein like 2 |
6832 |
0.24 |
chr6_40925892_40926043 | 0.52 |
UNC5CL |
unc-5 homolog C (C. elegans)-like |
76907 |
0.08 |
chr5_87437759_87438959 | 0.52 |
TMEM161B |
transmembrane protein 161B |
78089 |
0.11 |
chr14_69421781_69422763 | 0.52 |
ACTN1 |
actinin, alpha 1 |
8007 |
0.23 |
chr3_45686706_45687144 | 0.51 |
LIMD1-AS1 |
LIMD1 antisense RNA 1 |
43449 |
0.12 |
chr7_46020334_46020485 | 0.51 |
ENSG00000239004 |
. |
5372 |
0.27 |
chr1_66932158_66932309 | 0.51 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
66833 |
0.12 |
chr20_43182087_43182266 | 0.51 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
21606 |
0.13 |
chr8_106728883_106729056 | 0.51 |
RP11-642D21.2 |
|
30976 |
0.2 |
chr2_45901435_45901586 | 0.51 |
U51244.2 |
|
1105 |
0.57 |
chr14_69472810_69472961 | 0.50 |
ACTN1-AS1 |
ACTN1 antisense RNA 1 |
26127 |
0.19 |
chr13_114630352_114630503 | 0.50 |
GAS6 |
growth arrest-specific 6 |
63381 |
0.13 |
chr8_128265644_128265795 | 0.50 |
POU5F1B |
POU class 5 homeobox 1B |
160816 |
0.04 |
chr4_129260645_129260796 | 0.50 |
PGRMC2 |
progesterone receptor membrane component 2 |
50736 |
0.19 |
chr17_1987997_1988266 | 0.50 |
RP11-667K14.5 |
|
4844 |
0.12 |
chr2_218714298_218714449 | 0.50 |
TNS1 |
tensin 1 |
7490 |
0.27 |
chr17_78933014_78933165 | 0.50 |
CTD-2561B21.3 |
|
2424 |
0.18 |
chr9_107826117_107826807 | 0.50 |
ENSG00000201583 |
. |
32575 |
0.22 |
chr7_79775488_79775920 | 0.50 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
10633 |
0.29 |
chr3_99384870_99385021 | 0.49 |
ENSG00000263810 |
. |
25470 |
0.21 |
chr4_120130830_120131163 | 0.49 |
RP11-455G16.1 |
Uncharacterized protein |
2671 |
0.26 |
chr22_46392610_46393183 | 0.49 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
19887 |
0.12 |
chr17_48105880_48106284 | 0.49 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
27257 |
0.11 |
chr20_43964414_43964565 | 0.49 |
SDC4 |
syndecan 4 |
12575 |
0.11 |
chr3_123536812_123536963 | 0.49 |
ENSG00000207002 |
. |
3963 |
0.26 |
chr22_37892945_37893096 | 0.49 |
CARD10 |
caspase recruitment domain family, member 10 |
7067 |
0.14 |
chr15_74689731_74690089 | 0.49 |
CYP11A1 |
cytochrome P450, family 11, subfamily A, polypeptide 1 |
29829 |
0.11 |
chr21_39221535_39221777 | 0.49 |
KCNJ6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
63901 |
0.13 |
chr10_11799148_11799299 | 0.48 |
ECHDC3 |
enoyl CoA hydratase domain containing 3 |
9949 |
0.25 |
chr14_73190563_73190714 | 0.48 |
ENSG00000206751 |
. |
129401 |
0.05 |
chr2_55382682_55382833 | 0.48 |
RTN4 |
reticulon 4 |
43000 |
0.11 |
chr2_75119840_75119991 | 0.48 |
HK2 |
hexokinase 2 |
57618 |
0.12 |
chr6_114421482_114421633 | 0.48 |
RP3-399L15.3 |
|
11993 |
0.23 |
chr7_27718120_27718271 | 0.48 |
HIBADH |
3-hydroxyisobutyrate dehydrogenase |
15581 |
0.23 |
chr3_111488513_111488664 | 0.48 |
PHLDB2 |
pleckstrin homology-like domain, family B, member 2 |
37244 |
0.18 |
chr2_227623514_227623665 | 0.48 |
IRS1 |
insulin receptor substrate 1 |
40886 |
0.16 |
chr1_8078544_8078695 | 0.48 |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
2926 |
0.27 |
chr1_85786366_85786652 | 0.48 |
ENSG00000264380 |
. |
36216 |
0.12 |
chr11_76464159_76464310 | 0.48 |
RP11-21L23.4 |
|
15033 |
0.14 |
chr16_31075775_31076376 | 0.47 |
ZNF668 |
zinc finger protein 668 |
215 |
0.75 |
chr5_149697150_149697301 | 0.47 |
ARSI |
arylsulfatase family, member I |
14709 |
0.17 |
chr2_149514080_149514280 | 0.47 |
EPC2 |
enhancer of polycomb homolog 2 (Drosophila) |
66397 |
0.11 |
chr21_28942271_28942554 | 0.47 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
603580 |
0.0 |
chr3_172466504_172466655 | 0.47 |
ECT2 |
epithelial cell transforming sequence 2 oncogene |
1893 |
0.3 |
chr9_114721568_114721719 | 0.46 |
ENSG00000266315 |
. |
27263 |
0.16 |
chr17_597333_597484 | 0.46 |
VPS53 |
vacuolar protein sorting 53 homolog (S. cerevisiae) |
20541 |
0.16 |
chr11_120176796_120176947 | 0.46 |
POU2F3 |
POU class 2 homeobox 3 |
518 |
0.77 |
chr17_17642775_17643230 | 0.46 |
RAI1-AS1 |
RAI1 antisense RNA 1 |
31133 |
0.12 |
chr5_16539153_16539304 | 0.46 |
FAM134B |
family with sequence similarity 134, member B |
30121 |
0.18 |
chr2_47313810_47313961 | 0.45 |
AC073283.7 |
|
18924 |
0.18 |
chr15_93572424_93572985 | 0.45 |
CHD2 |
chromodomain helicase DNA binding protein 2 |
20608 |
0.22 |
chr14_25591538_25591689 | 0.45 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
72110 |
0.13 |
chr12_88704360_88704511 | 0.45 |
ENSG00000199245 |
. |
119784 |
0.06 |
chr17_73689039_73689190 | 0.45 |
SAP30BP |
SAP30 binding protein |
488 |
0.65 |
chr3_52124413_52124839 | 0.45 |
LINC00696 |
long intergenic non-protein coding RNA 696 |
27059 |
0.11 |
chr10_80911217_80911486 | 0.45 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
82559 |
0.1 |
chr14_51835224_51835375 | 0.45 |
ENSG00000201820 |
. |
114558 |
0.05 |
chr13_52920227_52920378 | 0.45 |
TPTE2P2 |
transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 2 |
48339 |
0.12 |
chr15_84517699_84517850 | 0.45 |
ENSG00000200444 |
. |
24069 |
0.23 |
chr2_33467839_33468340 | 0.45 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
640 |
0.79 |
chr11_92029038_92029189 | 0.44 |
FAT3 |
FAT atypical cadherin 3 |
56149 |
0.17 |
chr7_55131985_55132136 | 0.44 |
EGFR |
epidermal growth factor receptor |
45249 |
0.19 |
chr1_78005323_78005533 | 0.44 |
AK5 |
adenylate kinase 5 |
7636 |
0.25 |
chr22_36863560_36864238 | 0.44 |
TXN2 |
thioredoxin 2 |
13488 |
0.14 |
chr5_14154020_14154339 | 0.44 |
TRIO |
trio Rho guanine nucleotide exchange factor |
10350 |
0.32 |
chr18_56665589_56665740 | 0.44 |
ENSG00000251870 |
. |
72136 |
0.1 |
chr8_30278565_30278948 | 0.44 |
RBPMS |
RNA binding protein with multiple splicing |
21377 |
0.21 |
chr21_37222664_37222964 | 0.44 |
FKSG68 |
|
47913 |
0.16 |
chr13_52945814_52946215 | 0.44 |
ENSG00000199605 |
. |
28125 |
0.16 |
chr3_124512536_124512716 | 0.44 |
ITGB5-AS1 |
ITGB5 antisense RNA 1 |
12624 |
0.17 |
chr10_94725570_94725721 | 0.44 |
EXOC6 |
exocyst complex component 6 |
31586 |
0.2 |
chr17_76677483_76677634 | 0.44 |
ENSG00000252391 |
. |
15321 |
0.19 |
chr5_57751450_57751723 | 0.44 |
PLK2 |
polo-like kinase 2 |
4501 |
0.26 |
chr12_46796862_46797190 | 0.43 |
SLC38A2 |
solute carrier family 38, member 2 |
30376 |
0.2 |
chr14_73267837_73267988 | 0.43 |
ENSG00000206751 |
. |
52127 |
0.14 |
chr2_43152776_43153425 | 0.43 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
133368 |
0.05 |
chr15_74710605_74710756 | 0.43 |
SEMA7A |
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
15321 |
0.14 |
chr10_126725690_126725841 | 0.43 |
ENSG00000264572 |
. |
4326 |
0.24 |
chr2_19807324_19807591 | 0.43 |
OSR1 |
odd-skipped related transciption factor 1 |
249043 |
0.02 |
chr2_182654523_182654674 | 0.43 |
ENSG00000221023 |
. |
51265 |
0.14 |
chr11_64427589_64427881 | 0.43 |
AP001092.4 |
|
13864 |
0.15 |
chr2_111206449_111206764 | 0.43 |
RP13-1039J1.3 |
|
213 |
0.94 |
chr6_17928540_17928933 | 0.43 |
KIF13A |
kinesin family member 13A |
58958 |
0.14 |
chr17_63014430_63015230 | 0.42 |
RP11-583F2.5 |
|
33197 |
0.12 |
chr2_190258502_190258653 | 0.42 |
WDR75 |
WD repeat domain 75 |
47582 |
0.16 |
chr6_45621464_45621615 | 0.42 |
ENSG00000252738 |
. |
7698 |
0.32 |
chr15_57129370_57129631 | 0.42 |
ZNF280D |
zinc finger protein 280D |
81269 |
0.1 |
chr8_128919473_128919624 | 0.42 |
TMEM75 |
transmembrane protein 75 |
41043 |
0.15 |
chr17_79532915_79533078 | 0.42 |
NPLOC4 |
nuclear protein localization 4 homolog (S. cerevisiae) |
632 |
0.54 |
chr4_170038662_170038813 | 0.42 |
RP11-327O17.2 |
|
84208 |
0.08 |
chr10_105398515_105398780 | 0.42 |
SH3PXD2A |
SH3 and PX domains 2A |
22815 |
0.14 |
chr5_64358925_64359076 | 0.41 |
ENSG00000207439 |
. |
60196 |
0.16 |
chr3_81776683_81776834 | 0.41 |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
16022 |
0.31 |
chr8_53529590_53529741 | 0.41 |
RB1CC1 |
RB1-inducible coiled-coil 1 |
18929 |
0.24 |
chr3_115059944_115060095 | 0.41 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
193901 |
0.03 |
chr12_58818734_58818885 | 0.41 |
RP11-362K2.2 |
Protein LOC100506869 |
119098 |
0.06 |
chr1_154703230_154703438 | 0.41 |
ADAR |
adenosine deaminase, RNA-specific |
102860 |
0.05 |
chr2_69453257_69453408 | 0.41 |
ENSG00000199460 |
. |
43323 |
0.14 |
chr5_136554415_136554566 | 0.41 |
SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
94737 |
0.09 |
chr15_63031651_63031802 | 0.41 |
TLN2 |
talin 2 |
12437 |
0.2 |
chr3_52039773_52040512 | 0.41 |
RPL29 |
ribosomal protein L29 |
10184 |
0.09 |
chr17_45787218_45787648 | 0.41 |
TBKBP1 |
TBK1 binding protein 1 |
14803 |
0.13 |
chr6_105876584_105876735 | 0.41 |
PREP |
prolyl endopeptidase |
25700 |
0.25 |
chr12_13054850_13055147 | 0.41 |
GPRC5A |
G protein-coupled receptor, family C, group 5, member A |
7005 |
0.15 |
chr18_65266738_65266889 | 0.41 |
DSEL |
dermatan sulfate epimerase-like |
82596 |
0.11 |
chr15_67419351_67419566 | 0.41 |
SMAD3 |
SMAD family member 3 |
983 |
0.62 |
chr15_75986048_75986554 | 0.41 |
AC105020.1 |
Uncharacterized protein; cDNA FLJ12988 fis, clone NT2RP3000080 |
15629 |
0.09 |
chr7_64905809_64905960 | 0.41 |
ZNF92 |
zinc finger protein 92 |
67090 |
0.11 |
chr15_48665560_48665810 | 0.40 |
DUT |
deoxyuridine triphosphatase |
41082 |
0.14 |
chr3_194918550_194918921 | 0.40 |
XXYLT1 |
xyloside xylosyltransferase 1 |
13208 |
0.16 |
chr1_201500197_201500348 | 0.40 |
CSRP1 |
cysteine and glycine-rich protein 1 |
21688 |
0.15 |
chr9_133655761_133655912 | 0.40 |
ABL1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
54617 |
0.13 |
chr17_25711228_25711379 | 0.40 |
TBC1D3P5 |
TBC1 domain family, member 3 pseudogene 5 |
35261 |
0.17 |
chr1_61918584_61919140 | 0.40 |
NFIA |
nuclear factor I/A |
46518 |
0.19 |
chr2_33294167_33294318 | 0.40 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
65231 |
0.12 |
chr1_86617171_86617322 | 0.40 |
COL24A1 |
collagen, type XXIV, alpha 1 |
4875 |
0.34 |
chr6_43977935_43978086 | 0.40 |
ENSG00000265518 |
. |
2728 |
0.23 |
chr5_136147505_136147656 | 0.40 |
ENSG00000222285 |
. |
157415 |
0.04 |
chr1_846289_846488 | 0.40 |
SAMD11 |
sterile alpha motif domain containing 11 |
13872 |
0.11 |
chr6_16985892_16986043 | 0.40 |
STMND1 |
stathmin domain containing 1 |
116522 |
0.07 |
chr20_46558387_46558538 | 0.40 |
ENSG00000238785 |
. |
25370 |
0.21 |
chr7_73236720_73236871 | 0.40 |
CLDN4 |
claudin 4 |
5279 |
0.16 |
chr12_13347125_13347538 | 0.40 |
EMP1 |
epithelial membrane protein 1 |
2319 |
0.38 |
chr9_89894332_89894483 | 0.40 |
ENSG00000212421 |
. |
19042 |
0.28 |
chr13_30497661_30497812 | 0.40 |
LINC00572 |
long intergenic non-protein coding RNA 572 |
3052 |
0.37 |
chr7_1164562_1164713 | 0.40 |
C7orf50 |
chromosome 7 open reading frame 50 |
13239 |
0.12 |
chr2_15310901_15311052 | 0.40 |
NBAS |
neuroblastoma amplified sequence |
19545 |
0.3 |
chr9_111240432_111240727 | 0.40 |
ENSG00000222512 |
. |
119370 |
0.06 |
chr3_11243097_11243459 | 0.40 |
HRH1 |
histamine receptor H1 |
24439 |
0.24 |
chr14_71709023_71709174 | 0.40 |
AC004817.1 |
HCG2028611; Uncharacterized protein |
25636 |
0.21 |
chr17_49031674_49031909 | 0.39 |
SPAG9 |
sperm associated antigen 9 |
39507 |
0.14 |
chr8_118960890_118961041 | 0.39 |
EXT1 |
exostosin glycosyltransferase 1 |
161688 |
0.04 |
chr3_188067044_188067254 | 0.39 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
109497 |
0.07 |
chr1_234858071_234858911 | 0.39 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
113220 |
0.06 |
chr13_40638535_40638849 | 0.39 |
ENSG00000207458 |
. |
162272 |
0.04 |
chr21_40392911_40393288 | 0.39 |
ENSG00000272015 |
. |
126390 |
0.05 |
chr10_72123522_72123673 | 0.39 |
LRRC20 |
leucine rich repeat containing 20 |
17817 |
0.18 |
chr1_44794530_44794681 | 0.39 |
ENSG00000252146 |
. |
4245 |
0.2 |
chr13_43733384_43733535 | 0.39 |
DNAJC15 |
DnaJ (Hsp40) homolog, subfamily C, member 15 |
136120 |
0.05 |
chr11_130348758_130348944 | 0.39 |
ADAMTS15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
29982 |
0.21 |
chr8_30322063_30322214 | 0.39 |
RBPMS |
RNA binding protein with multiple splicing |
22005 |
0.23 |
chr6_150208883_150209034 | 0.39 |
RAET1E-AS1 |
RAET1E antisense RNA 1 |
2281 |
0.18 |
chr3_57935477_57935765 | 0.39 |
SLMAP |
sarcolemma associated protein |
32929 |
0.19 |
chr17_18122099_18122385 | 0.39 |
LLGL1 |
lethal giant larvae homolog 1 (Drosophila) |
6659 |
0.12 |
chr15_101498493_101498644 | 0.39 |
LRRK1 |
leucine-rich repeat kinase 1 |
39018 |
0.15 |
chr5_135329366_135329517 | 0.39 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
35143 |
0.15 |
chr1_16124336_16124487 | 0.39 |
FBLIM1 |
filamin binding LIM protein 1 |
32963 |
0.1 |
chr7_40337996_40338297 | 0.39 |
SUGCT |
succinylCoA:glutarate-CoA transferase |
163527 |
0.04 |
chr12_71054642_71054987 | 0.39 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
23594 |
0.24 |
chr7_152050844_152051077 | 0.39 |
ENSG00000253088 |
. |
48905 |
0.15 |
chr3_141080488_141080639 | 0.38 |
RP11-438D8.2 |
|
5416 |
0.25 |
chr10_101804735_101804886 | 0.38 |
CPN1 |
carboxypeptidase N, polypeptide 1 |
20341 |
0.16 |
chr2_18766689_18766840 | 0.38 |
NT5C1B |
5'-nucleotidase, cytosolic IB |
1587 |
0.31 |
chr18_20047269_20047420 | 0.38 |
CTAGE1 |
cutaneous T-cell lymphoma-associated antigen 1 |
49466 |
0.17 |
chr11_12840572_12840723 | 0.38 |
RP11-47J17.3 |
|
4567 |
0.24 |
chr2_181848570_181849184 | 0.38 |
UBE2E3 |
ubiquitin-conjugating enzyme E2E 3 |
2127 |
0.37 |
chr5_136806058_136806209 | 0.38 |
SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
28114 |
0.22 |
chr2_238209455_238209606 | 0.38 |
AC112715.2 |
Uncharacterized protein |
43796 |
0.17 |
chr17_46080195_46080690 | 0.38 |
RP11-6N17.10 |
|
6880 |
0.1 |
chr19_18788699_18789106 | 0.38 |
CRTC1 |
CREB regulated transcription coactivator 1 |
5585 |
0.15 |
chr7_151297671_151297822 | 0.38 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
31693 |
0.18 |
chr9_111870490_111871218 | 0.38 |
TMEM245 |
transmembrane protein 245 |
11371 |
0.19 |
chr7_69849817_69849968 | 0.38 |
AUTS2 |
autism susceptibility candidate 2 |
344233 |
0.01 |
chr2_121722334_121722485 | 0.38 |
ENSG00000221321 |
. |
70240 |
0.12 |
chr13_98862550_98862701 | 0.38 |
ENSG00000263399 |
. |
1847 |
0.29 |
chr6_17865598_17865749 | 0.38 |
KIF13A |
kinesin family member 13A |
48242 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.2 | 0.6 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.6 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.4 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.8 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.1 | 0.9 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.5 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.2 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.2 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.3 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.2 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.3 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.1 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.1 | 0.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.8 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.5 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.1 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.0 | GO:0060592 | mammary gland formation(GO:0060592) mammary placode formation(GO:0060596) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.0 | 0.4 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.2 | GO:0044319 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.0 | 0.1 | GO:0090493 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:1903170 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.0 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.1 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.6 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.6 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.4 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0061440 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) glomerular mesangium development(GO:0072109) |
0.0 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.3 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.0 | GO:2000757 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.1 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.0 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0031223 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.0 | 0.1 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.0 | 0.1 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.0 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.1 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.0 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:1990748 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0060840 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.5 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.2 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0051135 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.0 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.8 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.8 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 2.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0043034 | costamere(GO:0043034) |
0.0 | 5.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.0 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.6 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.7 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.3 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.5 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 2.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.3 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 1.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.0 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 1.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 2.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 1.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |